Womens Imaging: Page 543

Safeguard Scientific acquires $20 million stake in Rubicor

By AuntMinnie.com staff writers

Minimally invasive breast biopsy developer Rubicor Medical reported that Safeguard Scientifics has provided $20 million in growth capital, while ITX International Equity put up $5 million as part of a $30 million Series C financing round.

August 24, 2006

Fuji partners with NBCF

By AuntMinnie.com staff writers

Fujifilm Medical Systems USA has entered into collaboration with the National Breast Cancer Foundation (NBCF), according to the Dallas-based nonprofit charity.

August 24, 2006

Breast MRI takes on CT in hepatic lesions and intraductal carcinoma

By Shalmali Pal

Two new studies have examined the role of MRI and CT in breast cancer and subsequent metastatic disease. Radiologists in New York City sought to find out whether MRI should be used to differentiate benign and malignant lesions in patients with indeterminate CT findings. And Japanese researchers pitted MRI against multidetector-row CT (MDCT) for determining the lesion margins for surgical removal. They found that one modality was superior to the other.

August 24, 2006

Fischer sells remaining businesses, files Chapter 11

By AuntMinnie.com staff writers

Fischer Imaging of Denver said that it has signed a definitive agreement to sell its radiology, electrophysiology, and surgical (RE&S) business to contract manufacturer Byers Peak of Wheat Ridge, CO.

August 22, 2006

Ovarian metastasis shows distinct CT features in stomach versus colon cancer

By Shalmali Pal

Most nongenital cancers that spread to the ovaries originate in the gastrointestinal tract. Making the distinction between primary and metastatic ovarian tumors is essential for proper patient care, according to a study in the September issue of the American Journal of Roentgenology.

August 22, 2006

False negative for mammography resolved by tomosynthesis

This woman had her regular screening mammogram, which was rated as BI-RADS 1, or normal.

Some weeks later she returned because of a palpable lump in her breast. Ultrasound detected this lump and was determined through biopsy to be DCIS. Her mammogram was retrospectively reviewed and the cancer was deemed to be mammographically occult.

On review of the tomosynthesis image, taken at the same time as the mammogram, the cancer can be clearly seen near the skin line above the nipple.

This image is from a technology that is a work-in-progress and that does not have regulatory approval in certain global markets.

August 21, 2006

False positive for mammography resolved by tomosynthesis

An object on a conventional digital mammogram was highly suspicious for malignancy. The structure was seen in both the MLO and CC views, and persisted on the multiple diagnostic mammograms. The patient underwent biopsy and the structure was benign.

If you look at the corresponding tomosynthesis images, you see nothing malignant. The structure seen in the conventional mammogram was the result of overlapping tissues. Diagnosis was given as superimposed parenchyma.

At another height in the breast, a series of calcifications can be seen in the tomosynthesis cine loop. Because of the 3D nature of the tomosynthesis images, these are known to be within a few millimeters of the skin’s surface.

This image is from a technology that is a work-in-progress and that does not have regulatory approval in certain global markets.

August 21, 2006

Preop FDG-PET spots axillary involvement in breast cancer, may obviate biopsy

By Shalmali Pal

Surgeons should consider breast PET studies to determine if they can skip biopsy and proceed straight to axillary lymph node dissection (AND), according to a study in the Archives of Surgery. But the study authors cautioned that the PET exam must predict positive nodes with 100% specificity.

August 20, 2006

AuntMinnie.com Women's Imaging Insider

By Shalmali Pal

August 20, 2006

Multimodality breast CAD workstation improves diagnostic performance

By Erik L. Ridley

A computer-aided diagnosis (CAD) multimodality workstation can improve the performance of radiologists in differentiating malignant and benign breast lesions on mammography and sonography, according to research published in the August issue of Radiology.

August 16, 2006

NovaScan raises development capital

By AuntMinnie.com staff writers

Breast cancer imaging start-up NovaScan has raised $285,000 in equity funding from investors, with another $100,000 available to it through grants and loans.

August 15, 2006

Digi-Solve unveils digital mammo fee-per-procedure offering

By AuntMinnie.com staff writers

Outsource provider Digi-Solve has introduced a digital mammography fee-per-procedure program at a price point of $37.50 per exam, according to the Ponte Vedra Beach, FL-based firm.

August 14, 2006

Previous Page

Page 543 of 694

Next Page